Are you attending the Advances in Cell-Based Screening in Drug Discovery conference?
If you’re interested in integrating iPSC-based screening in your pipeline, don't miss the chance to talk to our team. They'll guide you through Ncardia's iPSC platform with relevant models and screening technology which can be integrated at any point of your discovery pipeline regardless of your therapeutic modality.
Let’s talk about how you can take advantage of our integrated iPSC-based platform.
We hope to see you at the conference! Visit our Poster #19 or click here to receive a download.
"A human iPSC-based platform to screen therapeutics for ALS using specific and robust phenotypic assays covering disease-relevant readouts"
Charles Leach,
Business Development Manager, Europe